SFGT for Persistent Anxiety and Depression

Last updated: March 10, 2025
Sponsor: GGZ Noord-Holland-Noord
Overall Status: Completed

Phase

N/A

Condition

Anxiety Disorders

Panic Disorders

Depression

Treatment

short-term schema focused group therapy

Clinical Study ID

NCT05942495
NL83423.018.22
  • Ages 18-65
  • All Genders

Study Summary

Rationale: Although there are effective treatments available for anxiety and depression, there is a large group of clients that does not benefit sufficiently from first-choice treatment. For this group of clients, no suitable alternative exists yet. One of the main hypothesis about maintaining factors is that there are underlying personality features that impede recovery. Schema focused therapy (SFT) is a transdiagnostic therapy focusing on underlying personality features. It has been proven to be an effective therapy for people with personality disorders and there are initial indications that SFT is also an effective treatment for anxiety and depressive symptoms. A short-term schema focused group therapy (SFGT) has been developed within GGZ-NHN, which is expected to benefit clients with persistent anxiety and depressive symptoms, but has not yet been studied.

Objective of the study: In the present study the effectiveness of short-term SFGT (protocol of De Jager, Burger & Groot) on (1) persistent anxiety and depressive symptoms, and (2) early maladaptive schemas (EMS), experiential avoidance and the mode of the healthy adult will be investigated.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Persistent anxiety or depression symptoms (at least moderate score at the subscaledepression (≥7 or anxiety ≥6 on the DASS-21).

  • History of at least one previous evidence-based therapy focused on anxiety,depression or PTSD according to the Dutch national guidelines.

  • Able to comprehend Dutch at a level sufficient to complete self-report.

Exclusion

Exclusion Criteria:

  • Clients with severe problems that need to be addressed first, including substanceabuse, psychosis, anxiety disorder, PTSD or depression that not have been treated.

  • Start of (or change in) medication which is not yet stabilized at the start ofthis study.

  • Psychosocial problems such as homelessness, no income or high debts which wouldmake the clients unable to participate in a group.

Study Design

Total Participants: 15
Treatment Group(s): 1
Primary Treatment: short-term schema focused group therapy
Phase:
Study Start date:
July 18, 2023
Estimated Completion Date:
February 02, 2025

Study Description

Study design: A Single Case Experimental Design (SCED), using repeated measures over four different phases.

Connect with a study center

  • Stichting GGZ Noord-Holland-Noord

    Heerhugowaard, North Holland 1703WC
    Netherlands

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.